This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.02089-06v1 81/8/3980    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ye, F.-C. Articles by Gao, S.-J. Search for Related Content PubMed PubMed Citation Articles by Ye, F.-C. Articles by Gao, S.-J.

Kaposi's Sarcoma-Associated Herpesvirus Promotes Angiogenesis by Inducing Angiopoietin-2 Expression via AP-1 and Ets1

Tumor Virology Program, Children's Cancer Research Institute,¹ Departments of Pediatrics,² Microbiology and Immunology,³ Molecular Medicine,⁴ Pathology,⁵ San Antonio Cancer Institute, The University of Texas Health Science Center, San Antonio, Texas,⁶ Tumor Virology Group, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China,⁷ Cancer Research United Kingdom Institute for Cancer Studies, University of Birmingham, Birmingham, United Kingdom,⁸ Institute of Pathology, Medizinische Hochschule Hannover, Hannover, Germany⁹

Received 25 September 2006/ Accepted 24 January 2007

Infection by Kaposi's sarcoma-associated herpesvirus (KSHV) is required for the development of Kaposi's sarcoma (KS), a highly inflammatory angiogenic tumor of endothelial cells commonly found in untreated AIDS patients. Angiopoietin 2 (Ang-2) modulates the vasculature during inflammation and angiogenesis, but the mechanism by which KSHV regulates Ang-2 expression has not been investigated. Here, we show that KSHV infection of primary human umbilical vein endothelial cells induced the expression and release of Ang-2, which in turn was required for KSHV-induced paracrine-dependent angiogenesis in vivo. Ang-2 was strongly expressed in small vessels and spindle tumor cells in KS tumors. Mechanistically, KSHV activated the Ang-2 promoter via AP-1 and Ets1 transcriptional factors, which were mediated by ERK, JNK, and p38 mitogen-activated protein kinase (MAPK) pathways. Our findings demonstrate the importance of Ang-2 in KS angiogenesis and define a novel role for AP-1 and MAPK pathways in regulating angiogenesis. This study also illustrates a distinct mechanism by which a tumor virus modulates vasculature to promote tumorigenesis and exemplifies the convergence of oncogenesis and angiogenesis pathways in tumor development.

Published ahead of print on 7 February 2007.

This article has been cited by other articles:

• Kuang, E., Tang, Q., Maul, G. G., Zhu, F. (2008). Activation of p90 Ribosomal S6 Kinase by ORF45 of Kaposi's Sarcoma-Associated Herpesvirus and Its Role in Viral Lytic Replication. J. Virol. 82: 1838-1850 [Abstract] [Full Text]  
• Efklidou, S., Bailey, R., Field, N., Noursadeghi, M., Collins, M. K. (2008). vFLIP from KSHV inhibits anoikis of primary endothelial cells. J. Cell Sci. 121: 450-457 [Abstract] [Full Text]  
• Depeille, P., Young, J. J., Boguslawski, E. A., Berghuis, B. D., Kort, E. J., Resau, J. H., Frankel, A. E., Duesbery, N. S. (2007). Anthrax Lethal Toxin Inhibits Growth of and Vascular Endothelial Growth Factor Release from Endothelial Cells Expressing the Human Herpes Virus 8 Viral G Protein Coupled Receptor. Clin. Cancer Res. 13: 5926-5934 [Abstract] [Full Text]  
• Qian, L.-W., Xie, J., Ye, F., Gao, S.-J. (2007). Kaposi's Sarcoma-Associated Herpesvirus Infection Promotes Invasion of Primary Human Umbilical Vein Endothelial Cells by Inducing Matrix Metalloproteinases. J. Virol. 81: 7001-7010 [Abstract] [Full Text]